Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02840994
Title A Trial of CV301 in Combination With Nivolumab Versus Nivolumab in Subjects With Previously Treated Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bavarian Nordic, Inc.
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

CV301 + Nivolumab

Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
H. Lee Moffitt Cancer Center & Research Institute, Inc. Tampa Florida 33612 United States Details
Investigative Clinical Research of Indiana Indianapolis Indiana 46260 United States Details
Metairie Oncologist, LLC Metairie Louisiana 70006 United States Details
NCI Bethesda Maryland 20892 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Novant Health Oncology Specialists Winston-Salem North Carolina 27103 United States Details
Millennium Oncology Houston Texas 77090 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field